| Pharmaceutical active ingredients: |
| Estrogens Conjugated |
| Available forms, composition and doses of Espauz: |
| Tablets; Oral; Estrogens Conjugated 0.625 mg |
| Espauz medical category: |
| Human:EstrogensOestrogens and progesterones and related synthetic drugs |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| G03CA57 - Conjugated Estrogens |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Glenmark Pharmaceuticals |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Espasmo-Ped | Pargeverine Hydrochloride | Stiefel Laboratories |
| Espasmosan | Belladonna; Papaverine Hydrochloride | Leofarma Comercio e Industria |
| Espasmosan Composto | Belladonna; Metamizole; Papaverine Hydrochloride | Leofarma Comercio e Industria |
| Espasmotropin | Homatropine | Sintesina |
| Espasmotropina | Atropine Sulfate; Papaverine Hydrochloride | Madariaga |
| Espa-Valept | Valproic Acid (Valproate Sodium) | Esparma |
| Espaven | Ranitidine | E. J. Gezzi Laboratorios |
| Espaven | Dimethicone; Vitamin B5 (Calcium Pantothenate) | Valeant Pharmaceuticals; ICN Pharmaceuticals |
| Espaven Alcalino | Aluminum Hydroxide; Dimethicone; Magnesium Hydroxide | Valeant Pharmaceuticals; ICN Pharmaceuticals |
| Espaven Antigas | Simethicone | E. J. Gezzi Laboratorios |